|The Titan catheter line consists of a highly navigable, large bore aspiration catheter and a smaller bore catheter for navigation and support.|
|Balt USA, LLC announced today it has obtained CE mark for the Titan aspiration catheter. The Titan catheter line consists of a highly navigable, large bore (.070″) aspiration catheter and a smaller bore (.036″) catheter for navigation and support. Obtaining the CE mark for Titan* enhances the Balt stroke portfolio as it will be available alongside the CatchView* revascularization stent, Vasco* catheters, Ballast long sheath and Hybrid guidewires to provide a complete stroke solution to the marketplace.
“Obtaining the CE mark for Titan strengthens Balt’s position in the rapidly growing ischemic stroke market,” said Pascal Girin, CEO at Balt. “Titan marks the sixth significant product approval obtained by Balt within the last year and is a testament to Balt’s commitment to bring a rapid succession of innovative products to the neurovascular community.”
*The Titan aspiration catheter, CatchView revascularization stent and Vasco catheters are not cleared or approved for sale in the United States.
About Balt USA, LLC